Compared with the null AAV9 vector, the endothelium-specific Gsdmd shRNA-knockdown AAV9 vector significantly improved the survival of the mice from 10% to 80% and decreased the release of IL-1β during endotoxemia (Figure 8, A and B). This evidence concerns the gene IL1B and serum lipopolysaccharide activity.